NIH Guide to Grants and Contracts

The NIH Guide for Grants and Contracts is our official publication for NIH grant policies, guidelines and funding opportunities. We publish daily, and issue a table of contents weekly. Learn more about the NIH Guide and subscribe today!

The old advanced search is still avaliable.

New Features:

  • Tabular view - You can now view the search results in table format.
  • Export to excel - Search results can now be exported to excel for reporting purposes.

Results: 1 to 25 of 1425

Display Results as:

Occupational Safety and Health Education and Research Centers (T42) - PAR-15-303

Organization: CDC 

Posting Date: 07-21-2015 

Expiration Date: 10-21-2019 

Activity Code: T42 

Summary: The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), invites grant applications for funding Education and Research Centers (ERCs) that are focused on occupational safety and health training, research training, education and outreach. NIOSH is mandated to provide an adequate supply of qualified personnel to carry out the purposes of the Occupational Safety and Health Act, and the ERCs are one of the principal means for meeting this mandate. ERCs are academic institutions that provide high-quality interdisciplinary graduate training, research training, continuing education, and outreach in the core occupational safety and health disciplines of industrial hygiene (IH), occupational health nursing (OHN), occupational medicine residency (OMR), and occupational safety (OS), as well as closely related allied disciplines. Research and research training are integral components of ERCs, with ERC faculty and NIOSH trainees conducting research on issues related to the NIOSH National Occupational Research Agenda (NORA). The ERCs also serve as regional resources for industry, labor, government, and the public. 

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) - PAR-18-530

Organization: NCI 

Posting Date: 12-21-2017 

Expiration Date: 01-08-2021 

Activity Code: R01 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic research to understand disease, or in applied research to assess risk, detect, prevent, diagnose, treat, and/or manage disease. The rationale is to deliver new capabilities to meet evolving requirements for technologies and methods relevant to the advance of research and delivery of care in pre-clinical, clinical and non-clinical settings, domestic or foreign, for conditions and diseases within the missions of participating institutes. This FOA specifies a partnership structure that is expected to help bridge gaps in knowledge and experience by engaging the strengths of academic, industrial, and other investigators. The partners on each application should establish an inter-disciplinary, multi-institutional research team to work in strategic alliance to implement a coherent strategy to develop and translate a solution to their chosen problem. They are expected to plan, design, and validate that it is will be suitable for end users. Each partnership should include at least one academic and one industrial organization. Each partnership should plan to transition a technology, method, assay, device, and/or system from a demonstration of possibility to a status useful in the chosen setting. Funding may be requested to enhance, adapt, optimize, validate, and otherwise translate technologies that address problems in biology, pathology, risk assessment, diagnosis, treatment, and/or monitoring of disease status. This FOA defines innovation as likelihood to deliver a new capability to end users.. This FOA will support clinical trials that test functionality, or validate performance in the chosen setting. This FOA is not intended to support commercial production, basic research projects, or straight clinical trials that lack translation as the primary motivation 

NIOSH Small Research Program (R03) - PAR-12-200

Organization: NIOSH 

Posting Date: 07-25-2012 

Expiration Date: 05-18-2018 

Activity Code: R03 

Summary: The purpose of this grant program is to develop an understanding of the risks and conditions associated with occupational diseases and injuries, to explore methods for reducing risks and for preventing or minimizing exposure to hazardous conditions in the workplace, and to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries.  

NIOSH Exploratory/Developmental Grant Program (R21) - PAR-12-252

Organization: NIOSH 

Posting Date: 07-27-2012 

Expiration Date: 05-18-2018 

Activity Code: R21 

Summary: The purpose of this grant program is to develop an understanding of the risks and conditions associated with occupational diseases and injuries, to explore methods for reducing risks and for preventing or minimizing exposure to hazardous conditions in the workplace, and to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries.  

Occupational Safety and Health Research (R01) - PAR-13-129

Organization: NIOSH 

Posting Date: 03-01-2013 

Expiration Date: 05-08-2018 

Activity Code: R01 

Summary: The purpose of this grant program is to develop an understanding of the risks and conditions associated with occupational diseases and injuries, to explore methods for reducing risks and for preventing or minimizing exposure to hazardous conditions in the workplace, and to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries.  

Mentored Research Scientist Development Award (K01) - PAR-13-245

Organization: NIOSH 

Posting Date: 07-03-2013 

Expiration Date: 05-18-2018 

Activity Code: K01 

Summary: The purpose of the K01 is to provide support and 75% protected time for an intensive, supervised (mentored) career development experience in occupational health and safety research leading to research independence. The goal of the NIOSH Mentored Research Scientist Development Award (K01) is to help ensure the availability of an adequate numbers of highly trained scientists and educators to address occupational safety and health critical issues.  

NIOSH Support for Conferences and Scientific Meetings (U13) - PAR-14-229

Organization: NIOSH 

Posting Date: 05-20-2014 

Expiration Date: 09-08-2019 

Activity Code: U13 

Summary: The purpose of the NIOSH Conference and Scientific Meeting Cooperative Program (U13) is to support high quality and impact scientific conferences/meetings that are relevant to NIOSHs scientific mission, program priorities, and to the public health. The conference cooperative agreement program is integral to the overall mission of NIOSH. An application should address and advance the field of occupational safety and health (http://www.cdc.gov/niosh/programs/ and http://www.cdc.gov/niosh/nora/default.html). A conference/scientific meeting is defined as a gathering, symposium, seminar, scientific meeting, workshop or any other organized and formal meeting where persons assemble or meet virtually to coordinate, exchange, and disseminate information or to explore or clarify a defined subject, problem, or area of knowledge. Applications for training-only events will not be considered under this announcement. For training opportunities, NIOSH recommends that an interested individual visit the NIOSH webpage for sponsored Education and Research Centers and Training Program Grants at http://www.cdc.gov/niosh/oep/default.html.  

NIOSH Support for Conferences and Scientific Meetings (R13) - PAR-14-246

Organization: NIOSH 

Posting Date: 06-03-2014 

Expiration Date: 09-08-2019 

Activity Code: R13 

Summary: The purpose of the NIOSH Conference Grant Program (R13) is to support high quality, investigator-initiated scientific conferences/meetings that are relevant to its scientific mission and to the public health. A conference/scientific meeting is defined as a gathering, symposium, seminar, scientific meeting, workshop or any other organized and formal meeting,whether conducted face-to-face or via the internet, where persons assemble or meet virtually to coordinate, exchange, and disseminate information or to explore or clarify a defined subject, problem, area of knowledge, or gaps in science, prevention/intervention or policies. 

AHRQ Health Services Research Demonstration and Dissemination Grants (R18) - PA-14-290

Organization: AHRQ 

Posting Date: 07-18-2014 

Expiration Date: 05-26-2018 

Activity Code: R18 

Summary: The Research Demonstration and Dissemination Grant (R18) is an award made by AHRQ to an institution/organization to support a discrete, specified health services research project. The project will be performed by the named investigator and study team. The R18 research plan proposed by the applicant institution/organization must be related to the mission and priority research interests of AHRQ. 

AHRQ Health Services Research Projects (R01) - PA-14-291

Organization: AHRQ 

Posting Date: 07-18-2014 

Expiration Date: 07-06-2018 

Activity Code: R01 

Summary: The Research Project Grant (R01) is an award made by AHRQ to an institution/organization to support a discrete, specified health services research project. The project will be performed by the named investigator and study team. The R01 research plan proposed by the applicant institution/organization must be related to the mission and priority research interests of AHRQ. 

Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant (R01) - RFA-FD-15-001

Organization: FDA 

Posting Date: 10-20-2014 

Expiration Date: 02-08-2018 

Activity Code: R01 

Summary: The goal of FDA's OPD grant program is to support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the product being developed will be superior to the existing therapy. FDA provides grants for clinical studies on safety and/or effectiveness that will either result in, or substantially contribute to, market approval of these products. Applicants must include in the application's Background and Significance section documentation to support the assertion that the orphan disease or condition to be studied is a rare disease or condition and an explanation of how the proposed study will either help support product approval or provide essential data needed for product development.  

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Therapeutic Agent Identification and Characterization to Support Therapeutic Discovery (R21/R33) - PAR-15-070

Organization: NINDS 

Posting Date: 12-12-2014 

Expiration Date: 05-08-2018 

Activity Code: R21/R33 

Summary: This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize potential therapeutic agents for neurological disorders. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) to advance projects to the point where they can meet the entry criteria for NINDS Cooperative Research to Enable and Advance Translational Enterprises program (CREATE) for biologics, biotechnology products, the Blueprint Neurotherapeutics Network (BPN) for small molecules, or other translational program.  

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Pharmacodynamics and In vivo Efficacy Studies for Small Molecules and Biologics/Biotechnology Products (R21/R33) - PAR-15-071

Organization: NINDS 

Posting Date: 12-12-2014 

Expiration Date: 05-08-2018 

Activity Code: R21/R33 

Summary: This FOA provides funding to conduct pharmacodynamics, pharmacokinetics, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to warrant further development to treat neurological disorders. Therapeutic agents may include but are not limited to small molecules, biologics or biotechnology-derived products. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) to advance projects to the point where they can meet the entry criteria for NINDS Cooperative Research to Enable and Advance Translational Enterprises program (CREATE) for biologics, biotechnology products, the Blueprint Neurotherapeutics Network (BPN) for small molecules, or other translational program.  

Short-Term Research Education Program to Increase Diversity in Health-Related Research (R25) - RFA-HL-16-008

Organization: NHLBI 

Posting Date: 11-07-2014 

Expiration Date: 02-21-2018 

Activity Code: R25 

Summary: The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The goal of this NHLBI R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral, and clinical research workforce in the mission areas of importance to NHLBI. To accomplish the stated goal, this funding opportunity announcement encourages the development of creative educational activities with a primary focus on Research Experiences. 

T32 Training Program for Institutions That Promote Diversity (T32) - RFA-HL-16-007

Organization: NHLBI 

Posting Date: 11-13-2014 

Expiration Date: 02-21-2018 

Activity Code: T32 

Summary: The purpose of this funding opportunity announcement (FOA) is toenhance the participation of individuals from diverse backgrounds underrepresented in cardiovascular, pulmonary, hematologic and sleep disorders research across the career development continuum. The NHLBIs T32 Training Program for Institutions That Promote Diversity is a Ruth L. Kirschstein National Research Service Award Program intended to support training of predoctoral and health professional students and individuals in postdoctoral training institutions with an institutional mission focused on serving health disparity populations not well represented in scientific research, or institutions that have been identified by federal legislation as having an institutional mission focused on these populations, with the potential to develop meritorious training programs in cardiovascular, pulmonary, hematologic, and sleep disorders. The NHLBIs T32 Training Program for Institutions That Promote Diversity is designed to expand the capability for biomedical research by providing grant support to institutions that have developed successful programs that promote diversity and serve health disparity populations and that offer doctoral degrees in the health professions or in health-related sciences. These institutions are uniquely positioned to engage minority and other health disparity populations in research, translation, and implementation of research advances that impact health outcomes, as well as provide health care for these populations. The primary goals of the T32 Training Program for Institutions That Promote Diversity are to:(1) contribute to the expansion of the future pool of individuals from diverse backgrounds underrepresented in research areas of interest to the NHLBI, (2) enable trainees to increase their competitiveness for peer-review research funding, (3) strengthen publication records of trainees, and (4) foster institutional environments conducive to professional development in the biomedical sciences. 

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate the Discovery of Neurotherapeutics (R21/R33) - RFA-NS-16-013

Organization: NINDS 

Posting Date: 11-03-2015 

Expiration Date: 05-08-2018 

Activity Code: R21/R33 

Summary: This funding opportunity announcement (FOA) encourages the development and validation of: 1) animal models and human tissue ex vivo systems that recapitulate the phenotypic and physiologic characteristics of a defined neurological disorder and/or 2) clinically feasible pharmacodynamic markers for therapeutics designed to treat neurological disease.The goal of this FOA is to promote a significant improvement in the translational relevance of animal models, ex vivo systems, testing paradigms, and endpoints that will be utilized to facilitate the development of neurotherapeutics. Ideally, endpoints proposed in applications for this FOA would have the potential to provide feasible and meaningful assessments of efficacy following therapeutic intervention that would be applicable in both preclinical and clinical settings.This FOA is not intended to support the development of animal and ex vivo model systems for the interrogation of disease etiology or for the identification of new drug targets. It is also not intended to support human clinical validation of model systems or pharmacodynamic markers. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts(IGNITE) focused on enabling the exploratory and early stages of drug discovery. 

Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp) - PA-15-109

Organization: NIAMS 

Posting Date: 02-04-2015 

Expiration Date: 04-05-2018 

Activity Code: (Admin Supp) 

Summary: The objective of the NIAMS STAR Program is to promote innovation and exploration of high-risk ideas by providing supplemental funding to early established investigators (EEIs). The STAR Program will support activities that effectively allow EEIs to expand and explore new opportunities within the broader scope of a currently funded, peer-reviewed research project to facilitate the transition from a single, structured research project to a research program.For the purpose of this program, NIAMS EEIs as those who have successfully renewed a first NIAMS-supported R01.  

NIDDK Research Education Program Grants for Courses for Skills Development (R25) - PAR-15-139

Organization: NIDDK 

Posting Date: 03-13-2015 

Expiration Date: 05-08-2018 

Activity Code: R25 

Summary: The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIDDK Research Education R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish this goal, this FOA will support creative educational activities that propose courses for skills development in the research areas relevant to the NIDDK. 

NIDDK Research Education Program Grants for Summer Research Experiences (R25) - PAR-15-140

Organization: NIDDK 

Posting Date: 03-13-2015 

Expiration Date: 05-08-2018 

Activity Code: R25 

Summary: The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.The over-arching goal of this NIDDK Research Education R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities that propose summer research experiences in the research areas relevant to the NIDDK. 

NIDDK Research Education Program Grants for Curriculum Development (R25) - PAR-15-138

Organization: NIDDK 

Posting Date: 03-13-2015 

Expiration Date: 05-08-2018 

Activity Code: R25 

Summary: The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIDDK Research Education R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish this goal, this FOA will support creative educational activities that propose the development of novel curricula or methods in the research areas relevant to the NIDDK. 

Enhancing Regulatory Science for the Risk Based Assessment of Emerging Manufacturing Technologies (U01) - PAR-15-187

Organization: FDA 

Posting Date: 04-17-2015 

Expiration Date: 05-01-2019 

Activity Code: U01 

Summary: The goal of this program is to support the advancement of regulatory science that can facilitate the implementation and the assessment of emerging manufacturing technology in the pharmaceutical sector. Emerging manufacturing technology can be viewed as a technology that has the potential to modernize the pharmaceutical manufacturing body of knowledge to support more robust, predictable, and/or cost-effective processes and with which the FDA has limited review or inspection experiences, due to its relative novelty. Examples of such elements include an innovative or novel: (1) product manufacturing technology, such as the dosage form; (2) manufacturing process (e.g., design, scale-up, and/or commercial scale); and/or (3) testing technology.  

Prevention Research in Mid-Life Adults (R01) - PA-15-098

Organization: NINR 

Posting Date: 01-22-2015 

Expiration Date: 01-25-2018 

Activity Code: R01 

Summary: This Funding Opportunity Announcement (FOA) seeks to stimulate research on mid-life adults (those 50 to 64 years of age) that can inform efforts to optimize health and wellness as individuals age, and prevent illness and disability in later years. 

Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01) - PA-15-100

Organization: NINR 

Posting Date: 01-27-2015 

Expiration Date: 01-25-2018 

Activity Code: R01 

Summary: This Funding Opportunity Announcement (FOA) encourages applications to improve health outcomes for women, infants and children, by stimulating interdisciplinary research focused on maternal nutrition and pre-pregnancy obesity. Maternal health significantly impacts not only the mother but also the intrauterine environment, and subsequently fetal development and the health of the newborn. 

Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01) - PA-15-127

Organization: NCI 

Posting Date: 02-26-2015 

Expiration Date: 01-25-2018 

Activity Code: R01 

Summary: The purpose of this funding opportunity announcement (FOA) is twofold: 1. to accelerate translational and clinical Phase I and II a/b safety and efficacy studies for substantiating measurable functional benefits of probiotic/prebiotic components and/or their combinations; and; 2. to understand the underlying mechanisms of their action(s), and variability in responses to these interventions. This FOA calls for interdisciplinary collaborations across scientific disciplines engaged in microbiome and pro/prebiotic research including, but not limited to: nutritional science, microbiology, virology, microecology and microbiome, genomics, immunology, computational biology, chemistry, bioengineering, as well as integration of omics and computational approaches in DNA technologies. This FOA will not support phase III clinical trials. 

Investigations on Primary Immunodeficiency Diseases (R01) - PAR-15-130

Organization: NIAID 

Posting Date: 03-04-2015 

Expiration Date: 05-08-2018 

Activity Code: R01 

Summary: This Funding Opportunity Announcement (FOA) is intended to support innovative investigations in primary immunodeficiency diseases.Of particular interest are the detection of primary immunodeficiency diseases, the identification of the molecular basis of these diseases, and the design and pre-clinical development of innovative therapies for these diseases.  

Current Search

Refine Your Results

Program Announcements (PAs)

Parent Announcments Only

Requests for Applications (RFAs)

Issuing Only

All Organizations

AHRQ

CDC

DHHS

DOJ

EPA

FDA

FIC

HRSA

NASA

NCATS

NCBDDD

NCCDPHP

NCCIH

NCEH

NCHSTP

NCI

NCID

NCIPC

NCMHD

NCPHI

NCRR

NEI

NHGRI

NHLBI

NIA

NIAAA

NIAID

NIAMS

NIBIB

NICHD

NIDA

NIDCD

NIDCR

NIDDK

NIEHS

NIGMS

NIH

NIMH

NIMHD

NINDS

NINR

NIOSH

NIP

NLM

OAR

OBSSR

OD

ODP

ODS

OPHR

ORD

ORI

ORIP

ORWH

OSC

Roadmap

SAMHSA

*On or After
*On or After
(e.g. "K" for K01 or K02, K05, etc.)
Back to Top